Pfizer Reenters Weight Loss Arena, Wins Bidding War to Buy Metsera for $10 Billion
Pfizer has secured a $10 billion deal to acquire Metsera, a fast-rising biotech company specializing in obesity and metabolic-disease treatments, ...
Pfizer has secured a $10 billion deal to acquire Metsera, a fast-rising biotech company specializing in obesity and metabolic-disease treatments, ...